Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06863987 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents

StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study was an randomized, double-Blind, placebo-controlled, multicenter Phase II/III study.
Trial Details
NCT Number NCT06863987
Lead Sponsor Shandong New Time Pharmaceutical Co., LTD
Conditions
(from sponsor)		 Essential Hypertension
Related terms Essential Hypertension
Enrollment 342 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov